{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-013221","form_type":"8-K","ticker":"BGS","cik":"0001278027","company_name":"B&G Foods, Inc.","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.416404+00:00","generated_at":"2026-06-12T07:23:14.981956+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"B&G Foods Q2 adjusted EPS $0.15 vs $0.07 YoY; reaffirms FY guidance","bullets":["Net sales $469.6M (-1.9% YoY) driven by Back to Nature divestiture; base business net sales +0.1%.","Gross margin 21.8% vs 16.0% YoY, driven by pricing and moderating input costs; adjusted EBITDA $68.5M (+26.4%).","Adjusted diluted EPS $0.15 vs $0.07 YoY; net income $10.6M vs $0.3M.","Full-year guidance: net sales revised to $2.11-2.13B; reaffirmed adjusted EBITDA $310-330M and adj. EPS $0.95-1.15.","Repurchased $24.4M of 5.25% senior notes due 2025 at 95.74% of par, resulting in $0.8M pre-tax gain."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-013221","json":"https://secwatch.observer/filing/0001558370-23-013221.json","markdown":"https://secwatch.observer/filing/0001558370-23-013221.md","text":"https://secwatch.observer/filing/0001558370-23-013221.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1278027/000155837023013221/0001558370-23-013221-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1278027/000155837023013221/bgs-20230803x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T07:23:14.981956+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c3a916fcfb1d79c4548a5b6685fd358627b814c0","claim":"B&G Foods, Inc. reported second quarter of 2023 results: revenue $469.6 million, net income $10.6 million, EPS $0.15 per diluted share. Guidance reaffirmed.","evidence_excerpt":"sheet with steady reduction in our net leverage.” Financial Results for the Second Quarter of 2023 Net sales for the second quarter of 2023 decreased $9.4 million, or 1.9%, to $469.6 million from $479.0 million for the second quarter of 2022. The decrease was primarily attributable to the Back to Nature divestiture. Net sales of Back to Nature , which the Company","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1278027/000155837023013221/0001558370-23-013221-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter of 2023"},{"label":"Revenue","value":"$469.6 million"},{"label":"Net income","value":"$10.6 million"},{"label":"EPS","value":"$0.15 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}